Efficacy and safety of gabapentin versus placebo to prevent the incidence of PostHerpetic Neuralgia: a double-blinded clinical trial

Trial Profile

Efficacy and safety of gabapentin versus placebo to prevent the incidence of PostHerpetic Neuralgia: a double-blinded clinical trial

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Jan 2017

At a glance

  • Drugs Gabapentin (Primary) ; Valaciclovir
  • Indications Herpes zoster; Postherpetic neuralgia
  • Focus Therapeutic Use
  • Acronyms PHN
  • Most Recent Events

    • 16 Nov 2015 Status changed from recruiting to completed, as reported by ISRCTN: Current Controlled Trials record.
    • 09 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top